EFFECT OF ANTI-APO1 ON SPONTANEOUS APOPTOSIS OF B-CELLS IN CHRONIC LYMPHOCYTIC-LEUKEMIA - THE ROLE OF BCL-2 AND INTERLEUKIN-4

被引:20
作者
MAINOUFOWLER, T
CRAIG, VA
COPPLESTONE, AJ
HAMON, MD
PRENTICE, AG
机构
[1] Department of Heamatology, Derrifod Hospital plymouth, England
关键词
APO1; CHRONIC LYMPHOCYTIC LEUKEMIA; INTERLEUKIN; 4; BCL-2; ONCOGENE;
D O I
10.3109/10428199509107902
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The cell surface protein apolipoprotein 1 (APO1) is expressed on various cell types including malignant lymphoid cells. Triggering of APO1 protein with antibody (Ab) induces apoptosis in APO1-expressing cells. We examined the effect of anti (alpha) APO1 Ab on spontaneous apoptosis (SA) and bcl-2 expression in B cell chronic lymphocytic leukaemia (B-CLL) in vitro. We also investigated the anti-apoptotic activity of interleukin 4 (IL4) on the aAPO1-induced apoptosis in B-CLL cells. Although expression of APO1 on B-CLL cells was not detectable by immunofluorescence, alpha APO1 Ab induced apoptosis in these cells. At 24 hours in culture the number of apoptotic cells was increased by a mean percentage (%) of 27% (range: 21-38) in only half of the cases studied. But in all twelve cases studied, at 48 hours alpha APO1 increased SA by a mean of 72% (range: 26-114) (P < .001) and at 72 hours, the mean % increase was 69% (range: 31-96) in 6/7 cases (P <.001). This effect was alpha APO1 concentration dependent. Interleukin 4 significantly protected B-CLL cells against alpha APO 1-induced apoptosis by a mean of 53% (range: 28-76) (P < .001). This protection was specific to IL4 and it was significantly reduced or abolished with alpha IL4 kb. Expression of bcl-2 protein in untreated cultures was not significantly different from that of the alpha APO1-treated cells; the mean equivalent of soluble fluorochrome (MESF) (range) was 4.9 (3.0-6.8) and 5.2 (3.5-6.0) respectively (P > 0.2). In fresh B-CLL cells the MESF (range) was 4.5 (2.4-6.6). Thus alpha APO1 Ab induced apoptosis in B-CLL cells by a pathway that is independent of bcl-2 expression and partially blocked by IL4.
引用
收藏
页码:301 / 308
页数:8
相关论文
共 33 条
[11]  
Nunez G., London L., Hockenbery D., Alexander M., McKean J.P., Deregulated bcl-2 gene expression selectively prolongs survival of growth-deprived haematopoietic cell lines, J. Immunol., 144, pp. 3602-3610, (1990)
[12]  
Garcia I., Martinou I., Tsujimoto Y., Martinou J.C., Prevention of programed cell death of sympathetic neurons by bcl-2 proto-oncogene, Science, 258, (1992)
[13]  
Boise L.H., Gonzalez-Garcia M., Postema C.E., Ding L., Lindstein T., Turka L.A., Mao X., Nunez G., Thompson C.B., Bcl-x. a bcl-2-related gene that functions as a dominant regulator of apoptotic cell death, Cell, 74, pp. 597-608, (1993)
[14]  
Oltvai Z.N., Milliman C.L., Korsmeyer S.J., Bcl-2 heterodimerizes in vivo with a conserved homolog, Bax, that accelerates programed cell death, Cell, 74, pp. 609-619, (1993)
[15]  
Pezzella F., Tse A.G.D., Cordell J.L., Pulford K.A.F., Gatter K.C., Mason D.Y., Expression of the bcl-2 oncogene protein is not specific for the 14
[16]  
18 chromosomal translocation, Am. J. Pathol., 137, pp. 225-232, (1990)
[17]  
Dancescu M., Rubio-Trujillo R., Biron G., Bron D., Delespesse G., Sarfati M., Interleukin 4 protects chronic lymphocytic leukaemia B cells from death by apoptosis and upregulates bcl-2 expression, J. Exp. Med., 176, pp. 1319-1326, (1992)
[18]  
Panayiotidis P., Ganeshaguru K., Jabbar S.A.B., Hoffbrand A.V., Interleukin-4 inhibits apoptotic cell death and loss of bcl-2 protein in B-chronic lymphocytic leukaemia cells in vitro, Br. J. Haematol., 85, pp. 439-445, (1993)
[19]  
Craig V.A., Mainou-Fowler T., Prentice A.G., Effect of interleukin-4 (IL-4) and dexamethasone on apptosis and bcl-2 expression in B-chronic lymphocytic leukaemia (B-CLL) in culture, Exp. Haematol., 21, (1993)
[20]  
Mainou-Fowler T., Craig V.A., Copplestone J.A., Hamon M.D., Prentice A.G., Interleukin-5 increases spontaneous apoptosis of B-cell chronic lymphocytic leukaemia (B-CLL)cells in vitro independently of bcl-2 expression, and is inhibited by IL-4, Blood, 84, pp. 2297-2304, (1994)